Jaspreet Jaggi, M.D., Ph.D., joined BeOne in 2020 as Senior Vice President, Clinical Portfolio Strategy.
Prior to joining BeOne, Dr. Jaggi spent more than 10 years at Novartis, serving in various leadership roles in clinical evaluation and clinical development. Most recently, as Vice President and Global Head of Oncology Clinical Evaluation, he led the scientific and strategic evaluation for both the internal oncology pipeline and external innovation. Additionally, he spearheaded the scientific and clinical evaluation of business development opportunities, including the acquisitions of GSK Oncology, AAA, Endocyte, CoStim and Admune, as well as strategic investments in CAR-T therapy and various in-licensing agreements. Dr. Jaggi also served as Global Clinical Program Head for Oncology Biosimilars, overseeing an integrated clinical development team across Sandoz and Novartis. Prior to Novartis, he served in various clinical development roles at Bristol Myers Squibb and Pfizer.
Dr. Jaggi earned an M.D. from Grant Medical College in Mumbai and a Ph.D. in pharmacology from the Weill Cornell Medical College/Memorial Sloan Kettering joint program. He was a Ludwig Center for Cancer Immunotherapy fellow at Memorial Sloan Kettering Cancer Center.